| Neda Mirzamani, | |
|
Ucsf Medical Center, 185 Berry Street, San Francisco, CA 94107 | |
| (516) 304-7495 | |
| Not Available |
| Full Name | Neda Mirzamani |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 26 Years |
| Location | Ucsf Medical Center, San Francisco, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093190852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZH0000X | Pathology - Hematology | A140427 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Clara Valley Medical Center | San jose, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| County Of Santa Clara | 1254244973 | 732 |
News Archive
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Alcohol treatment has come a long way from enforced isolation in asylums, and technological advancements are particularly promising in terms of their capacity to improve treatment effectiveness.
Biogeographical data is useful in screening for disease risk and drug sensitivity associated with certain ethnic groups. A team of researchers, including an investigator from Children's Hospital Los Angeles, has developed a tool to accurately identify the biogeography of worldwide individuals. Previous tools were accurate in identifying place of origin within homogeneous European populations but highly inaccurate for places with significant immigration, such as the U.S.
A new study describes the kinetics of the antibody response to the earliest approved vaccines against COVID-19, which were developed on an mRNA platform.
› Verified 6 days ago
| Entity Name | County Of Santa Clara |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699885079 PECOS PAC ID: 1254244973 Enrollment ID: O20040113000784 |
News Archive
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Alcohol treatment has come a long way from enforced isolation in asylums, and technological advancements are particularly promising in terms of their capacity to improve treatment effectiveness.
Biogeographical data is useful in screening for disease risk and drug sensitivity associated with certain ethnic groups. A team of researchers, including an investigator from Children's Hospital Los Angeles, has developed a tool to accurately identify the biogeography of worldwide individuals. Previous tools were accurate in identifying place of origin within homogeneous European populations but highly inaccurate for places with significant immigration, such as the U.S.
A new study describes the kinetics of the antibody response to the earliest approved vaccines against COVID-19, which were developed on an mRNA platform.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neda Mirzamani, Ucsf Medical Center, 185 Berry Street, San Francisco, CA 94107 Ph: () - | Neda Mirzamani, Ucsf Medical Center, 185 Berry Street, San Francisco, CA 94107 Ph: (516) 304-7495 |
News Archive
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Alcohol treatment has come a long way from enforced isolation in asylums, and technological advancements are particularly promising in terms of their capacity to improve treatment effectiveness.
Biogeographical data is useful in screening for disease risk and drug sensitivity associated with certain ethnic groups. A team of researchers, including an investigator from Children's Hospital Los Angeles, has developed a tool to accurately identify the biogeography of worldwide individuals. Previous tools were accurate in identifying place of origin within homogeneous European populations but highly inaccurate for places with significant immigration, such as the U.S.
A new study describes the kinetics of the antibody response to the earliest approved vaccines against COVID-19, which were developed on an mRNA platform.
› Verified 6 days ago
Dr. Elliott Scott Seeley, M.D., PH.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 513 Parnassus Ave, Hsw4, Suite 450a, San Francisco, CA 94143 Phone: 415-514-0738 | |
Lucy Han, Pathology Medicare: Medicare Enrolled Practice Location: 1101 Van Ness Ave, San Francisco, CA 94109 Phone: 415-600-2200 | |
Jason Yang, M.D., PH.D. Pathology Medicare: Medicare Enrolled Practice Location: 601 Van Ness Ave Apt 1028, San Francisco, CA 94102 Phone: 415-345-8836 | |
John C. Moretto, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 415-600-2200 Fax: 415-750-5001 | |
Karthik A Ganapathi, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-476-1000 | |
Dr. Scott R. Vandenberg, MD Pathology Medicare: Medicare Enrolled Practice Location: 513 Parnassus Ave, San Francisco, CA 94143 Phone: 415-502-7796 Fax: 415-476-1963 | |
Ronald Balassanian, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1600 Divisadero St, Ucsf/mt. Zion Medical Center, Room 200 Fna Clinic, San Francisco, CA 94115 Phone: 415-514-6642 Fax: 415-353-7676 |